In addition, GPR56 was found to have an inhibitory role in the mesenchymal differentiation and radioresistance of glioblastoma by negatively regulating the nuclear factor kappa B (NF-κB) signaling pathway (48). The gene discussed is ADGRG1; the disease is glioblastoma.